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Background
Immune evasion by suppression of host immunity is one
of the major mechanisms that tumors use to promote its
own survival. We have reported an abundance of immu-
nosuppressive monocytes (CD14+HLA-DRlow/neg) in
lymphoma (LYM), multiple myeloma (MM), glioblas-
toma multiforme (GBM), prostate cancer and renal cell
carcinoma (RCC). The number of these cells increases
with more aggressive disease and is associated with
decreased survival. In this study, we examine the RNA
expression profile of monocytes from cancer patients
compared to healthy donors (CNTRL) to identify differ-
entially affected functional pathways.
Methods
Monocytes were isolated from peripheral blood using
anti-CD14 immunomagnetic beads. RNA was extracted
from the monocytes and analyzed via whole genome
expression array (Affymetrix GeneChip Human Genome
U133 Plus 2.0 arrays). The number and frequency of the
HLA-DRlow/neg phenotypes were quantified, but the
population was not purified. Data was analyzed using
packages assembled from R and Bioconductor. Probe-
level data from the GeneChips was background-cor-
rected, normalized and summarized into a set of expres-
sion measures via the Robust Multi-array Average with
GC-content background (GCRMA) method. Several
search strategies were employed to find interesting gene
expression differences: (1) Directed searches for specific
genes, (2) Hypergeometric testing for Gene Set Enrich-
ment Analysis and (3) Gene Set Enrichment Analysis
using liner models. A variety of gene set was employed:
(A) Gene Sets derived from the Gene Ontology (GO)
database, (B) Gene Sets derived from the Kyoto Encyclo-
pedia of Genes and Genomics (KEGG) database and (C)
Gene Sets curated by the Broad Institute.
Results and conclusions
Monocytes RNA expression profiles were obtained from
5 CNTRL, 5 LYM, 6 MM, 4 GBM, 5 RCC, 1 ovarian
cancer. Comparison of the differences in monocyte
RNA expression in cancer patients to normal controls
found statistically highly significant under-expression of
immune function genes such as those in the TLR and
TNFaR superfamily and overexpression of genes regulat-
ing cell metabolism. These genes lie at the intersection
of several oncogenic and immunogenic gene sets and
their roles in immunosuppressive monocytes are under
active investigation. Gene Set Enrichment analysis of
gene expression profiles is a promising exploratory avenue
towards identifying novel immuno-regulatory pathways of
CD14+HLA-DRneg/low monocytes.
Authors’ details
1Internal Medicine, Mayo Clinic, Rochester, MN, USA. 2Transfusion Medicine,
Mayo Clinic, Rochester, MN, USA. 3Hematology, Mayo Clinic, Rochester, MN,
USA. 4Experimental Pathology, Mayo Clinic, Rochester, MN, USA.
Published: 7 November 2013
doi:10.1186/2051-1426-1-S1-P142
Cite this article as: Cordes et al.: Expression profiling of suppressive
monocytes (CD14+HLA-DRlow/neg) in cancer patients. Journal for
ImmunoTherapy of Cancer 2013 1(Suppl 1):P142.
1Internal Medicine, Mayo Clinic, Rochester, MN, USA
Full list of author information is available at the end of the article
Cordes et al. Journal for ImmunoTherapy of Cancer 2013, 1(Suppl 1):P142
http://www.immunotherapyofcancer.org/content/1/S1/P142
© 2013 Cordes et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
